|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-11-13
|
|
pubmed:abstractText |
Current methods for estimating the cost of illness inconsistently control for the effect of comorbid conditions. This analysis examines the implications of controlling for comorbid conditions on the estimated cost of illness. These implications are illustrated using the cost of osteoarthritis as an example.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1098-3015
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
329-34
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11705300-Adolescent,
pubmed-meshheading:11705300-Adult,
pubmed-meshheading:11705300-Aged,
pubmed-meshheading:11705300-Bias (Epidemiology),
pubmed-meshheading:11705300-Causality,
pubmed-meshheading:11705300-Child,
pubmed-meshheading:11705300-Child, Preschool,
pubmed-meshheading:11705300-Comorbidity,
pubmed-meshheading:11705300-Cost of Illness,
pubmed-meshheading:11705300-Female,
pubmed-meshheading:11705300-Health Care Costs,
pubmed-meshheading:11705300-Humans,
pubmed-meshheading:11705300-Infant,
pubmed-meshheading:11705300-Infant, Newborn,
pubmed-meshheading:11705300-Male,
pubmed-meshheading:11705300-Managed Care Programs,
pubmed-meshheading:11705300-Middle Aged,
pubmed-meshheading:11705300-Models, Econometric,
pubmed-meshheading:11705300-Organizational Case Studies,
pubmed-meshheading:11705300-Osteoarthritis,
pubmed-meshheading:11705300-Reproducibility of Results,
pubmed-meshheading:11705300-United States
|
|
pubmed:articleTitle |
Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective.
|
|
pubmed:affiliation |
Ingenix Pharmaceutical Services, 12125 Technology Drive, Eden Prairie, MN 55344, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
